Stelara Patent Deal Puts JandJ Back on Track to Revenue Forecast.

Published Date: 10 Jun 2023

Stelara may contribute more to J&J's 2024 and 2025 sales than Wall Street anticipates thanks to a legal agreement Johnson and Johnson reached with Amgen to postpone the release of a biosimilar version of the popular psoriasis treatment until January 2025.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

When Should Immunocompromised Individuals Receive a COVID Booster?

2.

Home Screening Appeals to Women Facing Healthcare Barriers

3.

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

4.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

5.

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot